Merck and Gilead announce partnership for long-acting HIV treatments

seekingalpha2021-03-15

Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

Austin韩
2021-03-16
Austin韩
Dope stuff
- xoxoll:
  Help me likE aNd comment
Lely84
2021-03-16
Lely84
Nice
- xoxoll:
  Help me like And comment
Atwosome
2021-03-16
Atwosome
Good joint venture
YsL
2021-03-16
YsL
Great
- johnnyboy:
  gr8
KFChen
2021-03-16
KFChen
Wow
- johnnyboy:
  good
CheeMang
2021-03-16
CheeMang
Nice 👍
- Ipster:
  Great

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/1163783799?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-03-15 22:54","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1163783799","market":"us","top_or_hot":-1,"title":"Merck and Gilead announce partnership for long-acting HIV treatments","media":"seekingalpha","content":"<div>\n<p>Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two ...</p>\n\n<a href=\"https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments\">网页链接</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck and Gilead announce partnership for long-acting HIV treatments</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck and Gilead announce partnership for long-acting HIV treatments\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 22:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two ...</p>\n\n<a href=\"https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://seekingalpha.com/news/3672687-merck-and-gilead-partnership-for-long-acting-hiv-treatments","article_id":"1163783799","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1163783799","pubTimestamp":1615820076,"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize lon","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"默沙东和Gilead宣布建立长期艾滋病毒治疗伙伴关系","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GILD":0.9,"MRK":0.9},"content_text":"Merck(MRK+1.19%)has partnered with Gilead Sciences(GILD+1.07%)to co-develop and co-commercialize long-acting treatments targeting people living with HIV.The combination will bring together two experimental therapies of companies: Gilead’s capsid inhibitor, lenacapavir, and Merck’s nucleoside reverse transcriptase translocation inhibitor, islatravir.The initial focus of the collaboration will be an oral formulation, and its studies are set to begin in H2 2021.Gilead and Merck will share global development and commercialization costs on a 60%/40% basis, respectively with Gilead leading the commercialization in the U.S. while Merck focuses on the EU and the rest of the world.The companies will equally share the global product revenues until a certain threshold is met, and after net product sales for the oral combination reaches $2B a year, Gilead and Merck will apportion any revenues above the threshold on a ratio of 65%/ 35% respectively.In January, ViiV Healthcare, a joint venture between GlaxoSmithKline(NYSE:GSK), Pfizer(NYSE:PFE)and Shionogi(OTCPK:SGIOY)received FDA approval for Cabenuva, cited as the first and only once-monthly, long-acting regimen for the treatment of HIV.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":325064797,"gmtCreate":1615852435519,"gmtModify":1703493916073,"author":{"id":"3573219888269818","authorId":"3573219888269818","name":"Austin韩","avatar":"https://static.tigerbbs.com/44226728b78011ea8b9a1c71fd7277b7","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3573219888269818","idStr":"3573219888269818"},"htmlText":"Dope stuff","listText":"Dope stuff","text":"Dope stuff","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325064797","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3803054,"gmtCreate":1615852476812,"gmtModify":1635753996267,"authorId":3572249185724220,"author":{"id":3572249185724220,"idStr":"3572249185724220","authorId":3572249185724220,"name":"xoxoll","avatar":"https://static.tigerbbs.com/8ed65c2962af2a6fbd414f4d6fe9e378","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325064797,"type":1,"supId":0,"prevId":0,"content":"Help me likE aNd comment ","text":"Help me likE aNd comment ","html":"Help me likE aNd comment "}],"langContent":"EN"},{"id":325017356,"gmtCreate":1615851058875,"gmtModify":1703493889068,"author":{"id":"3576653688169426","authorId":"3576653688169426","name":"Lely84","avatar":"https://static.tigerbbs.com/34f149aed6f506c1cee71310cc6dbf2c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3576653688169426","idStr":"3576653688169426"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325017356","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3803055,"gmtCreate":1615852487370,"gmtModify":1635753996144,"authorId":3572249185724220,"author":{"id":3572249185724220,"idStr":"3572249185724220","authorId":3572249185724220,"name":"xoxoll","avatar":"https://static.tigerbbs.com/8ed65c2962af2a6fbd414f4d6fe9e378","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325017356,"type":1,"supId":0,"prevId":0,"content":"Help me like And comment ","text":"Help me like And comment ","html":"Help me like And comment "}],"langContent":"EN"},{"id":325032255,"gmtCreate":1615849920077,"gmtModify":1703493870584,"author":{"id":"3571305152732730","authorId":"3571305152732730","name":"Atwosome","avatar":"https://static.tigerbbs.com/2085a92415ef32924f70d916d490adce","vip":1,"crmLevel":8,"crmLevelSwitch":0,"authorIdStr":"3571305152732730","idStr":"3571305152732730"},"htmlText":"Good joint venture&nbsp;","listText":"Good joint venture&nbsp;","text":"Good joint venture","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/325032255","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":325093403,"gmtCreate":1615848685502,"gmtModify":1703493849311,"author":{"id":"3571083769580822","authorId":"3571083769580822","name":"YsL","avatar":"https://static.tigerbbs.com/f258b1aa573da15fd74641181f7391bf","vip":1,"crmLevel":4,"crmLevelSwitch":0,"authorIdStr":"3571083769580822","idStr":"3571083769580822"},"htmlText":"Great","listText":"Great","text":"Great","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325093403","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3802550,"gmtCreate":1615848838802,"gmtModify":1635754029764,"authorId":3574470863456268,"author":{"id":3574470863456268,"idStr":"3574470863456268","authorId":3574470863456268,"name":"johnnyboy","avatar":"https://static.tigerbbs.com/3f1ae504243dd90e4d179be3cee5a24f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325093403,"type":1,"supId":0,"prevId":0,"content":"<u>gr8</u>","text":"<u>gr8</u>","html":"<u>gr8</u>"}],"langContent":"EN"},{"id":325090823,"gmtCreate":1615848421062,"gmtModify":1703493845125,"author":{"id":"3576990193651421","authorId":"3576990193651421","name":"KFChen","avatar":"https://static.tigerbbs.com/6830fa3fe8a82d29953fbb2e6153801e","vip":1,"crmLevel":6,"crmLevelSwitch":0,"authorIdStr":"3576990193651421","idStr":"3576990193651421"},"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/325090823","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3802551,"gmtCreate":1615848845188,"gmtModify":1635754029643,"authorId":3574470863456268,"author":{"id":3574470863456268,"idStr":"3574470863456268","authorId":3574470863456268,"name":"johnnyboy","avatar":"https://static.tigerbbs.com/3f1ae504243dd90e4d179be3cee5a24f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":325090823,"type":1,"supId":0,"prevId":0,"content":"<u>good</u>","text":"<u>good</u>","html":"<u>good</u>"}],"langContent":"EN"},{"id":322772294,"gmtCreate":1615846218818,"gmtModify":1703493826273,"author":{"id":"3573033813970769","authorId":"3573033813970769","name":"CheeMang","avatar":"https://static.tigerbbs.com/97f355a1d36ee0fb7321de6482b9764f","vip":1,"crmLevel":3,"crmLevelSwitch":0,"authorIdStr":"3573033813970769","idStr":"3573033813970769"},"htmlText":"Nice 👍&nbsp;","listText":"Nice 👍&nbsp;","text":"Nice 👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/322772294","repostId":1163783799,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":3802636,"gmtCreate":1615849605341,"gmtModify":1635754024847,"authorId":3560893220281291,"author":{"id":3560893220281291,"idStr":"3560893220281291","authorId":3560893220281291,"name":"Ipster","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":322772294,"type":1,"supId":0,"prevId":0,"content":"Great","text":"Great","html":"Great"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":98,"commentSize":15,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1163783799"}